Study of a new device for leaking heart valves
Part of Heart & circulation clinical trials.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 21 years old.
- Your mitral valve leak is moderate to severe or severe (grade 3+ or higher).
- You have symptoms like shortness of breath or fatigue despite taking the best medicines for your heart.
- A heart team has decided you are a good candidate for this procedure.
- You are willing to come back for all follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure to fix a leaky heart valve (mitral valve) in people with heart failure, with the goal of helping them tolerate and benefit from standard heart failure medicines. It asks whether adding this valve repair to optimized medicines is better than medicines alone.
This trial tests a procedure called transcatheter edge-to-edge repair (TEER) for people with a specific type of heart valve leak (functional mitral regurgitation) that is causing heart failure symptoms. The procedure is less invasive than open-heart surgery and aims to improve symptoms and quality of life.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
This trial tests a new device for people whose mitral valve leaks badly (grade 3+ or 4+) and who are not candidates for surgery. The device aims to fix the leak through a less invasive approach, and the study checks if it's safe and works well in daily life.
This trial studies an “epicardial” device placed during planned heart surgery to reduce mitral valve leaking (“mitral regurgitation”). If you have moderate-to-severe valve leak from ischemic heart disease and are already scheduled for heart surgery, this may help improve how well the valve works.
This trial tests a new device called MRace that may fix a leaky mitral valve without open-heart surgery. It's for people whose valve leaks severely and who can't have standard surgery due to other health issues.
Hear when a new Mitral Regurgitation Functional trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.